Mechanisms of Mortality in Early and Late Sepsis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
A recent hypothesis postulates that sepsis moves through different phases, with periods of enhanced inflammation alternating with periods of immune suppression. In this study we determined the levels of inflammation present during early and late septic deaths to examine whether death was due to hyperinflammation or immunosuppression. The murine model of sepsis induced by cecal ligation and puncture (CLP) was used. Complete blood counts, plasma interleukin-6 (IL-6) levels, and body weights were determined. Mice that died within the first 4 days had increased plasma levels of IL-6, indicating that there was activation of the immune system. Cecal resection on day 4 after CLP resulted in decreased abscess size, lower circulating neutrophil counts, decreased anemia, and improved survival compared to the results for mice that received only antibiotic and fluid therapy. All of the mice that died in the chronic phase of infection (after day 4) had positive peritoneal cultures containing significantly more bacteria than the cultures for surviving mice. After day 4, none of the surviving mice exhibited increases in the plasma levels of IL-6. Dying mice exhibited mixed IL-6 responses; for 41% of the mice there was never an increase in the IL-6 levels in the chronic phase, while for other mice the levels of IL-6 transiently increased prior to death. Peritoneal macrophages were obtained in the late phase of sepsis from moribund and healthy mice and were stimulated ex vivo. The cells from the moribund mice produced significantly less IL-6 than the cells obtained from healthy mice produced. These results indicate that in mice that die in the early phase there is uniformly increased inflammation. However, during the chronic phase of sepsis, some mice die with evidence of immunosuppression (increased bacterial growth and low IL-6 levels), while other mice die with immunostimulation (high IL-6 levels and bacterial growth). Determining the inflammatory status of individual patients may help guide appropriate, targeted therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · cited 1×
“Sepsis remains a significant clinical problem (34) despite recent advances in early goal-directed therapy (35), the use of activated protein C (6), and the use of low-dose glucocorticoids (3).”
BackgroundAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 2×
“A recent review of discharge records showed that there were an estimated 751,000 cases per year with an overall mortality rate of 29% (2).”
BackgroundEfficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132 · cited 1×
“Sepsis remains a significant clinical problem (34) despite recent advances in early goal-directed therapy (35), the use of activated protein C (6), and the use of low-dose glucocorticoids (3).”
BackgroundThe epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097 · cited 6×
“The data in this paper provide evidence that the proposed progression from SIRS to CARS is probably not linear but rather constantly changing and that it requires close observation.”
BackgroundInfluentialAnnane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Sepsis and septic shock—A review of laboratory models and a proposal
Wichterman, K. A., Baue, A. E., & Chaudry, I. H. (1980) · Journal of Surgical Research · doi:10.1016/0022-4804(80)90037-2 · Cited by 1,459 · cited 2×
“described (48), with some modifications.”
BackgroundMonocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173 · cited 1×
“This complex pattern was demonstrated in patients with meningococcal sepsis more than 16 years ago (46).”
BackgroundSepsis: A New Hypothesis for Pathogenesis of the Disease Process
Bone, R. C., Grodzin, C. J., & Balk, R. A. (1997) · Chest · doi:10.1378/chest.112.1.235 · Cited by 1,021
Sir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989 · cited 1×
“CARS is also described as a status of suppression, deficiency, or paralysis of the immune system (7).”
BackgroundSepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934 · cited 1×
“This time frame (days rather than hours) is more typical of the clinical course in septic patients, who more frequently die over several days (18).”
BackgroundBaker, C. C., Chaudry, I. H., Gaines, H. O., & Baue, A. E. (1983) · PubMed · Cited by 506
SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2001) · Shock · doi:10.1097/00024382-200116020-00001 · Cited by 481 · cited 1×
“A shift toward an anti-inflammatory immunosuppressive state has been postulated to occur in the later phases of sepsis (17, 29).”
BackgroundDownregulation of proinflammatory cytokine release in whole blood from septic patients
Ertel, W., Kremer, J., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O., & Schildberg, F. (1995) · Blood · doi:10.1182/blood.v85.5.1341.bloodjournal8551341 · Cited by 445 · cited 1×
“These defects are illustrated by reports that stimulation of whole blood obtained from septic patients does not result in proinflammatory cytokine production (14, 15, 22).”
BackgroundPlasma cytokine levels predict mortality in patients with acute renal failure
Simmons, E. M., Himmelfarb, J., Sezer, M. T., Chertow, G. M., Mehta, R. L., Paganini, E. P., Soroko, S., Freedman, S., Becker, K., Spratt, D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00512.x · Cited by 444 · cited 1×
“Other recent clinical studies demonstrated that there were persistent elevated levels in patients with abdominal sepsis (20) or septic patients with renal failure (40).”
BackgroundSix at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days
Remick, D. G., Bolgos, G. R., Siddiqui, J., Shin, J., & Nemzek, J. A. (2002) · Shock · doi:10.1097/00024382-200206000-00004 · Cited by 436
Self-citationAnnane, D., Sebille, V., & Charpentier, C. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00997-2 · Cited by 382
Management of Secondary Peritonitis
Wittmann, D. H., Schein, M., & Condon, R. E. (1996) · Annals of Surgery · doi:10.1097/00000658-199607000-00003 · Cited by 344
Antibiotics versus placebo for prevention of postoperative infection after appendicectomy.
Andersen, B. R., Kallehave, F. L., & Andersen, H. K. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001439.pub2 · Cited by 318 · cited 1×
“Antibiotic therapy has been proven to be effective for management of clinical intra-abdominal infections (1, 23) and improves survival in the CLP model of sepsis (28, 41, 42).”
BackgroundRole of Interleukin-6 in Mortality from and Physiologic Response to Sepsis
Remick, D. G., Bolgos, G., Copeland, S., & Siddiqui, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2751-2757.2005 · Cited by 230 · cited 1×
“We previously reported that after CLP, the plasma levels of IL-6 are substantially elevated 6 h after surgery in BALB/c mice (31, 32).”
BackgroundSelf-citationVoisin, L., Breuillé, D., Combaret, L., Pouyet, C., Taillandier, D., Aurousseau, E., Obled, C., & Attaix, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118586 · Cited by 223 · cited 1×
“Using a different model of sepsis, it has been shown that the loss of body weight after day 5 is due to increased skeletal muscle proteolysis (44).”
BackgroundImmunopathologic Alterations in Murine Models of Sepsis of Increasing Severity
Ebong, S., Call, D., Nemzek, J., Bolgos, G., Newcomb, D., & Remick, D. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6603-6610.1999 · Cited by 221 · cited 1×
“Within 24 h of CLP, significant leukopenia that affected primarily the lymphocytes developed (12) (Fig.”
BackgroundSelf-citationRadiologic Evaluation in Lung Cancer
Shaffer, K. (1997) · Chest · doi:10.1378/chest.112.4_supplement.235s · Cited by 184
Intensive care unit management of intra-abdominal infection
Marshall, J. C., & Innes, M. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000087326.59341.51 · Cited by 184 · cited 1×
“Antibiotic therapy has been proven to be effective for management of clinical intra-abdominal infections (1, 23) and improves survival in the CLP model of sepsis (28, 41, 42).”
BackgroundIMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSIS: MEDIATORS, MACROPHAGES, LYMPHOCYTES AND APOPTOSIS
Ayala, A., & Chaudry, I. H. (1996) · Shock · doi:10.1097/00024382-199606001-00007 · Cited by 168 · cited 1×
“Several reports have also documented suppression of macrophage function following cecal ligation and puncture (4, 47).”
BackgroundHumane Endpoints in Shock Research
Nemzek, J. A., Xiao, H.-Y., Minard, A. E., Bolgos, G. L., & Remick, D. G. (2003) · Shock · doi:10.1097/01.shk.0000101667.49265.fd · Cited by 163 · cited 3×
“and hypothermia would die within 1 to 3 days (27).”
BackgroundSelf-citationTherapeutic Intervention and Targets for Sepsis
Rice, T. W., & Bernard, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104356 · Cited by 158 · cited 1×
“Sepsis remains a significant clinical problem (34) despite recent advances in early goal-directed therapy (35), the use of activated protein C (6), and the use of low-dose glucocorticoids (3).”
BackgroundALTERATIONS IN TISSUE GLUCOSE UPTAKE DURING THE HYPERGLYCEMIC AND HYPOGLYCEMIC PHASES OF SEPSIS
Maitra, S. R., Wojnar, M. M., & Lang, C. H. (2000) · Shock · doi:10.1097/00024382-200005000-00006 · Cited by 135 · cited 1×
“Other studies defined the phases of the CLP model based on blood glucose levels (11, 21).”
MethodCytokine Therapeutics for the Treatment of Sepsis: Why has Nothing Worked?
Remick, D. G. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392567 · Cited by 125 · cited 1×
“This information about the nature of the inflammatory response in different phases of sepsis may explain the failure of previous trials with cytokine inhibitors, since it was assumed that all septic patients died from an exuberant inflammatory response to infection (30).”
ResultSelf-citationIMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSIS
Ayala, A., & Chaudry, I. H. (1996) · Shock · doi:10.1097/00024382-199610001-00007 · Cited by 125
Antibiotic Treatment in a Murine Model of Sepsis: Impact on Cytokines and Endotoxin Release
Vianna, R. C. S., Gomes, R. N., Bozza, F. A., Amancio, R. T., Bozza, P. T., de David, C., & Castro-Faria-Neto, H. C. (2004) · Shock · doi:10.1097/01.shk.0000111828.07309.26 · Cited by 123
Turnbull, I. R., Javadi, P., Buchman, T. G., Hotchkiss, R. S., Karl, I. E., & Coopersmith, C. M. (2004) · Shock · doi:10.1097/01.shk.0000108399.56565.e7 · Cited by 108
ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSIS: MEDIATORS OF INCREASED MORBIDITY
Newcomb, D., Bolgos, G., Green, L., & Remick, D. G. (1998) · shock · doi:10.1097/00024382-199808000-00005 · Cited by 92 · cited 2×
“Clinical peritonitis may originate from a defect in an abdominal viscus, such as an acute intestinal perforation (49), that progresses to sepsis, resulting in high morbidity and mortality in both experimental animals (28, 48) and patients (2, 24).”
BackgroundSelf-citationVolk, H., Thieme, M., Ruppe, U., Heym, S., Döcke, W. D., Manger, D., Zuckerman, S., Golosubow, A., Nieter, B., Klug, H., et al. (1993) · Springer eBooks · doi:10.1007/978-3-642-77405-8_40 · Cited by 89 · cited 1×
“During CARS there is depression of the immune system with functional defects in monocyte antigen presentation, formation of oxygen species, and cytokine secretion (10, 45).”
BackgroundAntibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Vianna, R. C. S., Gomes, R. N., Bozza, F. A., et al. (2004) · PubMed · doi:10.1097/01.shk.0000111828.07309.21 · Cited by 83
Antibiotics versus placebo for prevention of postoperative infection after appendicectomy.
Andersen, B., Kallehave, F., & Andersen, H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001439 · Cited by 82
Yang, S., Zhou, M., Fowler, D. E., & Wang, P. (2002) · Critical Care Medicine · doi:10.1097/00003246-200212000-00018 · Cited by 77 · cited 1×
“The CLP model of sepsis has previously been described to have at least two phases, a hypodynamic phase and a hyperdynamic phase (50, 52).”
Remick, D. G., Call, D. R., Ebong, S., Newcomb, D. E., Nybom, P., Nemzek, J. A., & Bolgos, G. L. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00001 · Cited by 76 · cited 1×
“Previous work in our lab (32) and by other workers (9, 42) has documented that deaths that occur during the early phase of CLP-induced sepsis are due to excessive inflammation (33), but the later stages of sepsis are not as well described.”
BackgroundSelf-citationMortality and bacteriology of sepsis following cecal ligation and puncture in aged mice
Hyde, S., Stith, R. D., & McCallum, R. E. (1990) · Infection and Immunity · doi:10.1128/iai.58.3.619-624.1990 · Cited by 69 · cited 2×
“The murine model of cecal ligation and puncture (CLP) is a well-described model of sepsis with features similar to those of clinical peritonitis, including polymicrobial infection (5, 19).”
BackgroundXiao, H., & Remick, D. G. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000151049.19253.54 · Cited by 66 · cited 1×
“phase of infection exhibited a significant weight gain (32, 51).”
BackgroundSelf-citationMajetschak, M., Flach, R., Heukamp, T., et al. (1997) · doi:10.1097/00005373-199712000-00002 · Cited by 54 · cited 1×
“These defects are illustrated by reports that stimulation of whole blood obtained from septic patients does not result in proinflammatory cytokine production (14, 15, 22).”
BackgroundSignificance of intraoperative peritoneal culture of fungus in perforated peptic ulcer
Shan, Y.-S., Hsu, H.-P., Hsieh, Y.-H., Sy, E. D., Lee, J.-C., & Pw, L. (2003) · British journal of surgery · doi:10.1002/bjs.4267 · Cited by 50 · cited 1×
“These infections generate a peritoneal inflammatory response to polymicrobial organisms derived from the gastrointestinal tract (16, 38).”
BackgroundProtegrin-1 increases bacterial clearance in sepsis but decreases survival
Steinstraesser, L., Burghard, O., Nemzek, J. A., Fan, M.-H., Merry, A. C., Remick, D. G., Su, G. L., Steinau, H.-U., & Wang, S. C. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00034 · Cited by 43 · cited 1×
“Antibiotic therapy has been proven to be effective for management of clinical intra-abdominal infections (1, 23) and improves survival in the CLP model of sepsis (28, 41, 42).”
BackgroundSelf-citationSelective macrophage suppression during sepsis
Ellaban, E., Bolgos, G. L., & Remick, D. G. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.12.010 · Cited by 39 · cited 1×
“IL-6 levels were determined since previous work demonstrated that in the early phases of sepsis production of this cytokine closely correlates with sepsis mortality (13).”
BackgroundSelf-citationLatifi, S. Q., O’Riordan, M. A., Levine, A. D., & Stallion, A. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.06.015 · Cited by 30 · cited 1×
“Other recent clinical studies demonstrated that there were persistent elevated levels in patients with abdominal sepsis (20) or septic patients with renal failure (40).”
BackgroundScott, M. J., Cheadle, W. G., Hoth, J. J., Peyton, J. C., Subbarao, K., Shao, W.-H., & Haribabu, B. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.5.936-941.2004 · Cited by 25 · cited 1×
“rise to a polymicrobial infection (5, 19, 37).”
BackgroundSepsis: A follow-up of cytokine production in different phases of septic patients
Martins, G. A. R., Carvalho, M. D. G., & Gattass, C. R. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.5.585 · Cited by 20 · cited 1×
“A clinical study performed with 17 patients also demonstrated that IL-6 levels became elevated when the patients became moribund (25).”
BackgroundDong, L.-W., Yang, J., Tong, L.-J., Tang, C., & Liu, M.-S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00102-1 · Cited by 16 · cited 1×
“Other studies defined the phases of the CLP model based on blood glucose levels (11, 21).”
MethodWang, X., Ebong, S., Call, D. R., Newcomb, D. E., Bolgos, G. L., & Remick, D. G. (2002) · Inflammation · doi:10.1023/a:1016515712344 · Cited by 10 · cited 1×
“Several reports have also documented suppression of macrophage function following cecal ligation and puncture (4, 47).”
BackgroundSelf-citation
Cited by
Immunodesign of experimental sepsis by cecal ligation and puncture
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.214 · Cited by 2,209
Animal models of sepsis and sepsis-induced kidney injury
Doi, K., Leelahavanichkul, A., Yuen, P. S. T., & Star, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39421 · Cited by 580
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Self-citationThe changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
Boomer, J. S., Green, J. M., & Hotchkiss, R. S. (2014) · Virulence · doi:10.4161/viru.26516 · Cited by 317
Current Murine Models of Sepsis
Lewis, A. J., Seymour, C. W., & Rosengart, M. R. (2016) · Surgical Infections · doi:10.1089/sur.2016.021 · Cited by 303
Metadata
- Authors
- Xiao, H., Siddiqui, J., & Remick, D. G.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2006-09
- Volume
- 74
- Issue
- 9
- Pages
- 5227-5235
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2162561105
- Cited by
- 194
- References
- 50
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.